Physiomics plc (PYC) ORD GBP0.004
0.005p
(1.16%)
Physiomics plc ORD GBP0.004
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
- Add to watchlist
- Create an alert
- This stock can be held in a
0.005p
(1.16%)
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Physiomics plc ORD GBP0.004
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
0.005p
(1.16%)
Physiomics plc ORD GBP0.004
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Eurozone industrial output unexpectedly drops
13 March 2026 10:05
(Sharecast News) - Eurozone industrial production unexpectedly contracted at its sharpest rate in nine months in January, as output declining across all major categories except energy.
-
Physiomics secures follow-on contract with existing client
15 December 2025 09:47
(Sharecast News) - Data science and biostatistics company Physiomics has secured a follow on contract worth up to £169,000 with an existing UK-based client.
-
Physiomics scores new contract with long standing client
16 July 2025 07:54
(Sharecast News) - Mathematical modelling and biostatistics firm Physiomics said on Wednesday that it had secured a new contract with long-standing client, Numab Therapeutics.
-
Physiomics total income grows in FY25, pre-tax losses improve
14 July 2025 08:46
(Sharecast News) - Data science and biostatistics firm Physiomics said on Monday that both total income and pre-tax losses would exceed market expectations for the financial year ended 30 June.
-
Physiomics secures two new contracts, names head of biometrics unit
16 June 2025 09:04
(Sharecast News) - Data science and biostatistics company Physiomics said on Monday that it had secured two new contracts with a UK-headquartered clinical-stage biopharmaceutical company.
-
Physiomics scores 'sizeable contract extension'
29 May 2025 09:47
(Sharecast News) - Data science and biostatistics company Physiomics said on Thursday that it has secured a "sizeable contract extension award" with an existing large pharmaceutical client.
-
Physiomics secures new contract with UK client
9 May 2025 09:10
(Sharecast News) - Data science and biostatistics company Physiomics revealed on Friday that it has secured a contract award with a new UK client.
-
Physiomics project gets regulatory and ethical approval
8 January 2025 14:12
(Sharecast News) - Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate UK-funded 'PREDICT-ONC' project had received both regulatory...
-
Physiomics announces new modelling and data sciences manager
4 November 2024 12:11
(Sharecast News) - Physiomics announced the appointment of Mark Davies as its head of quantitative pharmacology and data science on Monday.
-
Physiomics secures new contract from existing pharma client
17 September 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000...
-
Physiomics secures new contract from existing pharma client
17 September 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000...
-
Physiomics re-engages with DoseMe for personalised dosing software
14 June 2024 09:51
(Sharecast News) - Physiomics, a mathematical modelling and data science specialist focussed on therapeutics and personalised medicine, has re-engaged with DoseMe to implement its personalised dosing...
Company announcements Announcements
-
Holding(s) in Company
20 March 2026 09:45
Physiomics
-
Result of WRAP Retail Offer
18 March 2026 14:55
Physiomics
-
WRAP Retail Offer for up to £110,000.00
17 March 2026 07:01
Physiomics
-
WRAP Retail Offer for up to £110,000.00
17 March 2026 07:01
Physiomics
-
Completion of Placing and WRAP Retail Offer Launch
17 March 2026 07:00
Physiomics
-
Completion of Placing and WRAP Retail Offer Launch
17 March 2026 07:00
Physiomics
-
General Meeting Request
16 March 2026 07:00
Physiomics
-
Result of WRAP Retail Offer
13 March 2026 07:00
Physiomics
-
Result of WRAP Retail Offer
13 March 2026 07:00
Physiomics
-
Interim Results
16 February 2026 08:37
Physiomics
-
Physiomics Awarded New Contract
12 February 2026 07:00
Physiomics
-
Holding(s) in Company
2 February 2026 11:40
Physiomics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2026. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.